STOCK TITAN

Schedule 13G/A: KCK Ltd. Holds 0% of NeuroPace Inc Common Stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

KCK Ltd., a Bermuda entity, filed an amendment on Schedule 13G reporting zero beneficial ownership of NeuroPace Inc common stock (CUSIP 641288105). The filing indicates KCK Ltd. holds no sole or shared voting or dispositive power and represents 0.0% of the class. The document checks the appropriate rule designation and states that items related to group ownership, parent holding company identification and ownership on behalf of another person are not applicable. The filing is signed by KCK Ltd.'s secretary, certifying the accuracy of the statement.

Positive

  • Compliance disclosure: The amendment fulfills Schedule 13G reporting requirements and clarifies the filer holds no beneficial interest.
  • Clarity on control: The filing explicitly states no sole or shared voting or dispositive power, removing ambiguity about influence over the issuer.

Negative

  • None.

Insights

TL;DR: This amendment confirms no ownership interest by KCK Ltd., reflecting a non-material disclosure with limited governance implications.

The filing clearly states KCK Ltd. holds no shares and exercises no voting or dispositive power over NeuroPace Inc. Because the reported aggregate ownership is zero, there is no change to shareholder composition or control rights documented here. The disclosure satisfies Schedule 13G reporting obligations and indicates the filer is not acting as part of a group and has no parent/ subsidiary relationships relevant to this security.

TL;DR: Reporting zero beneficial ownership produces no market impact and serves primarily as a compliance filing.

The form provides a straightforward ownership statement: 0 shares, 0% of class, and no voting or dispositive powers. From an investor-materiality perspective, the amendment is neutral because it does not alter outstanding share distribution or signal accumulation or disposition by an affiliate. The filing does, however, document the filer's organizational details and confirms the absence of group affiliations related to this position.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



KCK LTD.
Signature:/s/ Raphael Metz
Name/Title:Secretary
Date:09/03/2025

FAQ

What does KCK Ltd. report for NeuroPace Inc (NPCE) ownership?

KCK Ltd. reports 0 shares beneficially owned, representing 0.0% of NeuroPace Inc common stock (CUSIP 641288105).

Does KCK Ltd. have voting or dispositive power over NPCE shares?

No. The filing states 0 sole voting power, 0 shared voting power, 0 sole dispositive power, and 0 shared dispositive power.

Is KCK Ltd. filing as part of a group or on behalf of another person?

No. The Schedule indicates the filer is not part of a group and ownership on behalf of another person is marked Not Applicable.

Where is KCK Ltd. organized?

The filing lists KCK Ltd.'s place of organization as Bermuda and provides a Bermuda business address.

Does this Schedule 13G/A change NeuroPace's shareholder composition?

No. Since the reported aggregate amount is 0 shares (0.0%), the filing does not change shareholder composition or control.
Neuropace Inc

NASDAQ:NPCE

NPCE Rankings

NPCE Latest News

NPCE Latest SEC Filings

NPCE Stock Data

500.28M
25.36M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MOUNTAIN VIEW